HD-OPM Archive
Topics › Brain health & dementia

Low-dose lithium shows neuroprotective signals and lower dementia risk in a review

Louis Nervegna · Jun 11, 2026 · ♥ 8 reactions · 0 comments · original Facebook post
Brain health & dementia
AI summary & key facts

Louis shares a JAMA Psychiatry narrative review concluding lithium has neuroprotective effects across cellular, imaging and epidemiologic studies. Low-dose lithium below psychiatric doses preserves neurons and gray matter, cumulative exposure is associated with lower dementia risk, and early trials in mild cognitive impairment look favorable.

#lithiumHD #dementiaHD #alzheimersHD

Research cited

📝 Narrative Review: #Lithium, a long-standing mood stabilizer, demonstrates convergent neuroprotective and neurotrophic effects relevant to #Dementia and #AlzheimerDisease.

Evidence across cellular, preclinical, human #neuroimaging, and #epidemiologic studies indicates that lithium upregulates anti-apoptotic proteins, boosts neurotrophic factors, inhibits tau-relevant kinase pathways, and stabilizes #mitochondrial function.

Low-dose lithium, which is below standard #psychiatric dosing, preserves neuronal viability and gray matter, and cumulative exposure is associated with reduced dementia risk.

Early clinical trials in mild cognitive impairment suggest favorable biomarker and cognitive outcomes, supporting prospective studies of low-dose lithium as a disease-modifying treatment.

Paper · JAMA Psychiatry · 2026The 25-Year Evolution of Lithium as a Disease-Modifying Agent in DementiaImportance Lithium, a long-established cornerstone therapy for bipolar disorder, is a biologically plausible disease-modifying agent for neurodegenerative disorders, including mild cognitive impairment (MCI) and Alzheimer disease (AD). Observations Rather than targeting a single pathology like amyloid or tau, lithium acts across multiple cellular resilience pathways. Chronic lithium exposure induces the…jamanetwork.comNo photo description available.
← newer: Vitamin D receptor agonist plus chemotherapy proved safe in older: Vegetable intake correlates with slower epigenetic aging, as →